The Human Immunodeficiency Virus Type 1 Ribosomal Frameshifting Site Is an Invariant Sequence Determinant and an Important Target for Antiviral Therapy

Journal of Virology- United States

doi 10.1128/jvi.78.4.2082-2087.2004

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Microbiology


Related search